Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 226.4 SEK -1.14% Market Closed
Market Cap: 30.7B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vitrolife AB
Cost of Revenue Peer Comparison

Comparables:
BIOG B
BONEX
B
BINV
SOBI
BIOA B

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Cost of Revenue
-kr1.5B
CAGR 3-Years
-39%
CAGR 5-Years
-25%
CAGR 10-Years
-25%
Biogaia AB
STO:BIOG B
Cost of Revenue
-kr346.3m
CAGR 3-Years
-20%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Cost of Revenue
-kr61.6m
CAGR 3-Years
-41%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
B
BioInvent International AB
STO:BINV
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Cost of Revenue
-kr5.4B
CAGR 3-Years
-18%
CAGR 5-Years
-13%
CAGR 10-Years
-18%
BioArctic AB
STO:BIOA B
Cost of Revenue
-kr50.9m
CAGR 3-Years
-30%
CAGR 5-Years
-10%
CAGR 10-Years
N/A

See Also

What is Vitrolife AB's Cost of Revenue?
Cost of Revenue
-1.5B SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Cost of Revenue amounts to -1.5B SEK.

What is Vitrolife AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-25%

Over the last year, the Cost of Revenue growth was 3%. The average annual Cost of Revenue growth rates for Vitrolife AB have been -39% over the past three years , -25% over the past five years , and -25% over the past ten years .

Back to Top